American Medical Association, 271: 908–924.
Cohen S. A. Fitzgerald R. J. Khan S. R. A. Khan 2004 The effect of a switch to ziprasidone (Geodon) in an adult population with autistic disorders: Chart review of naturalistic open label treatment. Journal of Clinical Psychiatry, 65: 110–113.
Comings E. D. 1990 Tourette Syndrome and human behavior. California., Hope, Duarte
Jr., Cook E. H. R. Rowlett, C. Jaseiskis, B. Leventhal 1992 Fluoxetine treatment of children and adults with autistic disorder and mental retardation. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 4:, 739–745.
J. Couzin 2004 Volatile chemistry: Children and antidepressants. Science, 305: 468–470.
Delong G. R. Teague L. A. Kaufman M. M. 1998 Effect of fluoxetine (Prozac) treatment in young children with idiopathic autism. Developmental Medicine and Child Neurology, 40: 551–562.
et al. Dodman N. H. 1987 Investigation into the use of narcotic antagonists in the treatment of stereotypic behavior pattern (crib biting) in the horse. American Journal of Veterinary Research, 48: 311–319.
Donovan S. J. Stewart J. W. Nunes E. W. 2000 Divalproex treatment of youth with explosive temper and mood liability. A double-blind placebocontrolled crossover design. American Journal of Psychiatry, 157: 818– 820.
Edwards J. G. Anderson L. 1999 Systematic review and guide to selective serotonin reuptake inhibitors. Drugs, 57: 507–533.
M. Fankhauser, Karumanchi V., M. German, A. Yates, Karumanchi S. D 1992 A double-blind, placebo- controlled study of the efficacy of transdermal clonidine in autism. Journal of Clinical Psychiatry, 53, 3:, 77–82.
Fieve R. R. 1994 Prozac: Questions and answers for patients, family and physicians. New York., Avon
A. Gedye 1989 Episodic rage and aggression attributed to frontal lobe seizures. Journal of Mental Deficiency Research, 33: 369–379.
A. Gedye 1992 Anatomy of self-injurious, stereotypic, and aggressive movements: Evidence for involuntary explanation. Journal of Clinical Psychology, 48, 6:, 766–778.
C. Gillberg 1991 The treatment of epilepsy in autism. Journal of Autism and Developmental Disorders, 21: 61–77.
Gordon C. T. State R. C Nelson J. E. Hamburger S. D. Rapoport J. L. 1993 A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Archives of General Psychiatry, 50: 441–447.
T. Grandin 1984 A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Archives of General Psychiatry, 50: 441–447.
T. Grandin 1992 An inside view of autism.. (eds.), E. Schopler (eds.), G. B. Mesibov. High-functioning individuals with autism. New York, Plenum, pp. 105–126.
T. Grandin, M. Scariano 1986 An inside view of autism.. (eds.), E. Schopler (eds.), G. B. Mesibov. High- functioning individuals with autism. New York, Plenum, pp. 105–126.
P. Hardy M. 1989 National Conference of the Autism Society of America. Seattle, July 19–22, 1989 (personal communication).. Washington, Lecture with no published paper.
K. Horvath, Perman J. A. 2002 Autism and gastrointestinal symptoms. Current Gastroentorology Reports, 4: 251–258.
K. Jamison R. 1993 Touched with fire. New York., Free Press
Knivesberg A. M. Reichelt K. L. T. Hoien, M. Nodland 2002 A randomized controlled study of dietary intervention in autistic syndromes. Nutritional Neurosciences, 4: 251–261.
H. Kwon 2004 Tardive dykinesia in an autistic patient treatment with risperidone. American Journal of Psychiatry, 161: 757–758.
P. Lerman, T. Lerman-Sagie, S. Kivity 1991 Effect of early corticosteroid therapy for Landau-Kleffner syndrome. Developmental Medicine and Child Neurology, 33: 257–266.
L. Lewis 1998 Special Diets for Special Kids. Arlington, Texas., Future Horizons
Lewis L. S. 2005 Gf and Cf plain and simple. Autism Asperger Digest Magazine, Jan/Feb., pp. 10–11.
Lindsay R. L. Aman M. G. 2003 Pharmocologic therapies and treatment for autism. Pediatric Annals, 32: 671–676.
et al. A. Martin, L. Scahill, Anderson G. M. Aman M. 2004 Weight and leptin changes among risperidone treatment youths with autism: 6-month prospective data. American Journal of Psychiatry, 161: 1125–1127.
J. Martineau, C. Barthelemy, B. Garreau, G. Lelord 1985 Vitamin B6, magnesium and combined B6?Mg. Therapeutic effects in childhood autism. Biological Psychiatry, 20: 467–478.
J. Martineau, C. Barthelemy, G. Lelord 1986 Long-term effects of combined vitamin B6?magnesium administration in an autistic child. Biological Psychiatry, 21: 511–518.
Mathews A. W. Abboud A. L. 2005 FDA raises concerns about ADHD drugs. Wall Street Journal, June 29, pp. D1 and D5.
McClellan J. M. Werry J. S. 2003 Evidence based treatments in child and adolescent psychiatry. Journal of American Academy of Child and Adolescent Psychiatry. pp.
McDougle C. J. Kem D. L. Posey D. J. 2003 Core Series: Use of ziprasi-done for maladaptive symptoms in youths with autism. Journal of American Academy of Child and Adolescent Psychiatry, 41: 921–927.
McCracken J. T. J. McGough, B. Shah, P. Cronin, et al. D. Hong 2002 Risperdone in children with autism and serious behavioral problems. New England Journal of Medicine, 347: 314–321.
C. Millward, M. Ferrita, S. Calver, G. Connell-Jones 2004 Gluten and casein free diets. Cochrane Database Systems Review, 2: CD003498.
J. Panksepp, P. Lensing 1991 Brief report: a synopsis of an open-trial of naltrexone treatment of autism with four children. Journal of Autism and Developmental Disorders, 21, 2:, 135–140.
Plioplys A. V. 1994 Autism: electroencephalogram abnormalities and clinical improvement with valproic acid. Archives of Pediatrics and Adolescent Medicine, 148: 220–222.
D. Rapp 1991 Is this your child? Discovering and treating unrecognized allergies. New York., William Morrow
et al. Ratey J. J. 1987 Autism: The treatment of aggressive behaviors. Journal of Clinical Psychopharmacology 7, 1:, 35–41.
Richardson A. J. P. Montgomery 2005 The Oxford-Durham study — a randomized controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder. Pediatrics, 115: 1360– 1366.
et al. R. Ricketts 1993 Fluoxetine treatment of severe self-injury in young adults with mental retardation. Journal of the American Academy of Child and Adolescent Psychiatry, 32, 4:, 865–869.
B. Rimland 1994 Parent ratings of behavioral effects of drugs and nutrients. San Diego, California., Autism Research Institute
B. Rimland 1995 Children's shots: no longer a simple decision. Autism Research Review 9 (1), p. 1–7.
J. Rosack 2004 FDA issues controversial black box warning. Psychiatric News, 29 (21):, 1 and 48.
Sandman C. A. Barron J. L. H. Colman 1990 An orally administered opiate blocker, naltrexone, attenuates self-injurious behavior. American Journal on Mental Retardation, 95, 1:, 93–102.
Sheehan D. V. Beh M. B. J. Ballenger, G. Jacobsen 1980 Treatment of endogenous anxiety with phobic, hysterical and hypochondriacal symptoms. Archives of General Psychiatry, 37: 51–59.
Swann A. C. Shoaib A. M. Bowers T. C. 1993 The manic syndrome: factors which may predict a patient's response to lithium, carbamazepine and valproate. Journal of Psychiatry and Neuroscience, 18 (2):, 61–66.
Trivedi H. K. B. Wang, J. Gonzalez-Heydrich 2005 Anti-epileptic drugs (AEDs) in the treatment of aggression in children and adolescents, Child and Adolescent Psychopharmacology News, vol. 10, no. 1, pp. 6–10.
L. Tsai 2001 Taking the Mystery Out of Medications. Arlington, Texas., Future Horizons
P. Waldman 2005 Mercury and Tuna: U.S. Advice Leaves Lots of Question, The Wall Street Journal, August 1, pp. 1 and 5.
A. Walters, R. Barrett, C. Feinstein, A. Mercurio, W Hole 1990 A case report of naltrexone treatment of self- injury and social withdrawal in autism. Journal of Autism and Developmental Disorders, 20, 2:, 169–176.
Whittington C. J. T. Kendall, P. Fonagy, D. Cotrell, A. Cotgrove, E. Bod-dington 2004 Selective serotonin reuptake inhibitors in childhood depression: Systematic review of published versus unpublished data. Lancet, 363:
